SCHEMBL10108258

SCHEMBL10108258

Cc1ccc(C(=O)N/N=C2\CCc3c(Cl)cc(Cl)c(O)c32)c(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 5/20 0.56
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 6/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM1A O60341 3/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 2/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39
TP53 P04637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
LMNA P02545 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668792 0.85 LMNA (0.46) PIK3CGNPC1RAB9ASMN1; SMN2POLB
SCHEMBL10108245 0.85 LMNA (0.46) PIK3CGNPC1RAB9ASMN1; SMN2POLB
SCHEMBL10108249 0.85 MAPT (0.56) NPC1RAB9ASMN1; SMN2MAPTL3MBTL1
SCHEMBL10108255 0.77 KDM1A (0.48) NPC1RAB9ASMN1; SMN2POLBMAPT
SCHEMBL10108247 0.77 RAB9A (0.44) NPC1RAB9ASMN1; SMN2POLBMAPT
SCHEMBL10108251 0.75 MAPT (0.50) NPC1RAB9ASMN1; SMN2POLBMAPT
SCHEMBL10108254 0.74 SIRT1 (0.43) NPC1RAB9ASMN1; SMN2MAPTL3MBTL1
SCHEMBL683923 0.72 PIK3CG (1.00) PIK3CGNPC1POLBMAPTL3MBTL1
SCHEMBL684718 0.71 PIK3CG (0.84) PIK3CGNPC1SMN1; SMN2POLBMAPT
SCHEMBL684827 0.71 PIK3CG (0.63) PIK3CGNPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012024488-A2 SYNERGISTIC FUNGICIDAL AND ALGICIDAL COMPOSITIONS INCLUDING 7-HYDROXY-INDANONE BENZOYLHYDRAZONES AND COPPER DOW AGROSCIENCES LLC (US) 2012-02-23 WO disclosed
US-20120045522-A1 SYNERGISTIC FUNGICIDAL AND ALGICIDAL COMPOSITIONS INCLUDING 7-HYDROXY-INDANONE BENZOYLHYDRAZONES AND COPPER DOW AGROSCIENCES LLC (US) 2012-02-23 US disclosed
US-20120045522-A1 SYNERGISTIC FUNGICIDAL AND ALGICIDAL COMPOSITIONS INCLUDING 7-HYDROXY-INDANONE BENZOYLHYDRAZONES AND COPPER DOW AGROSCIENCES LLC (US) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120045522-A1 SYNERGISTIC FUNGICIDAL AND ALGICIDAL COMPOSITIONS INCLUDING 7-HYDROXY-INDANONE BENZOYLHYDRAZONES AND COPPER ERG28, CYP3A7, UGT1A7 PIK3CG 3263/4885NPC1 1728/4885RAB9A 4431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.